Tvardi Therapeutics
Price & Volume
Stats
See more52W Range | $3.78-$43.65 |
Market Cap | $242.2M |
Shares Short | 885,749 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.25 |
News
See moreYahoo Finance • 16 days ago
Tvardi Therapeutics GAAP EPS of -$0.59 beats by $0.22
Yahoo Finance • 17 days ago
TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Yahoo Finance • 20 days ago
TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Yahoo Finance • 30 days ago
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
About
CEO | Dr. Imran Alibhai Ph.D. |
Address | 3 Sugar Creek Center Boulevard, Sugar Land, TX, United States, 77478 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
